August 18, 2017 3:14 AM ET

Biotechnology

Company Overview of Ironwood Pharmaceuticals, Inc.

Executive Profile

Julie H. McHugh

AgeTotal Calculated CompensationThis person is connected to 10 Board Members in 10 different organizations across 11 different industries.

See Board Relationships
53$300,423

Background

Ms. Julie H. McHugh served as the Chief Operating Officer of Endo International plc from March 13, 2010 to May 29, 2013 and its subsidiary, Endo Pharmaceuticals Solutions Inc., from March 2010 to May 29, 2013. Ms. McHugh served as the Chief Executive Officer and President of Nora Therapeutics, Inc. Prior to Nora Therapeutics, she served as Company Group Chairman for Worldwide Virology Business Unit at Johnson & Johnson from 2006 to 2008. From 2004 to 2006, she served ...

Corporate Headquarters

301 Binney Street
Cambridge, Massachusetts 02142

United States

Phone: 617-621-7722
Fax: 617-494-0480

Board Members Memberships

Director
Director
Director
Director
2010-Present
Director
2014-Present
Director
2014-Present
Independent Director
2015-Present
Independent Director
2017-Present
Director

Education

BS
Pennsylvania State University
MBA
Saint Joseph's University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Calculated Compensation$300,423
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chairman, Chief Executive Officer and President
Allergan plc
$1.0M
Pascal Soriot CEO & Executive Director
AstraZeneca PLC
$2.4M
Christophe Weber Presidednt, CEO & Representative Director
Takeda Pharmaceutical Company Limited
$495.0M
Peter S. Greenleaf Chairman & CEO
Sucampo Pharmaceuticals, Inc.
$653.0K
A. J. Kazimi MBAFounder, Chairman, Chief Executive Officer and President
Cumberland Pharmaceuticals Inc.
$698.0K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ironwood Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.